The effect of fibrinogen concentrate on perioperative bleeding in transurethral resection of the prostate: a double‐blind placebo‐controlled and randomized study

Essentials Perioperative bleeding during prostate surgery is still a common morbidity. Anticoagulant and antiplatelet medications contribute to the risk of hemorrhage and prolonged hospital stay. Multiple pharmacological agents have been proposed, but none of them have been widely accepted. It is crucial to find a safe and effective modality to reduce hemorrhage.

[1]  A. Jeppsson,et al.  Preoperative supplementation with fibrinogen concentrate in cardiac surgery: A randomized controlled study. , 2016, British journal of anaesthesia.

[2]  J. Langhoff‐Roos,et al.  Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial. , 2015, British journal of anaesthesia.

[3]  J. Fraser,et al.  Efficacy and safety of fibrinogen concentrate in trauma patients--a systematic review. , 2014, Journal of critical care.

[4]  A. Najafi,et al.  Prophylactic administration of fibrinogen concentrate in perioperative period of total hip arthroplasty: a randomized clinical trial study. , 2014, Acta Medica Iranica.

[5]  A. Hanke,et al.  Effects of Fibrinogen Concentrate as First-line Therapy during Major Aortic Replacement Surgery: A Randomized, Placebo-controlled Trial , 2013, Anesthesiology.

[6]  C. Wild,et al.  Systematic review of the efficacy and safety of fibrinogen concentrate substitution in adults , 2012, Acta anaesthesiologica Scandinavica.

[7]  M. Spannagl,et al.  Observational study of fibrinogen concentrate in massive hemorrhage: evaluation of a multicenter register , 2011, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[8]  D. Spahn,et al.  Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review , 2011, Critical care.

[9]  W. Voelckel,et al.  Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy , 2011, Critical care.

[10]  C. Long,et al.  Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. , 2010, Artificial organs.

[11]  A. Haverich,et al.  Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. , 2009, The Journal of thoracic and cardiovascular surgery.

[12]  S. Skrtic,et al.  Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery , 2009, Thrombosis and Haemostasis.

[13]  A. Haverich,et al.  Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study , 2009, British journal of anaesthesia.

[14]  J. Ingerslev,et al.  Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo‐controlled clinical trial , 2009, Journal of thrombosis and haemostasis : JTH.

[15]  S. R. Bueno,et al.  Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high‐risk severe bleeding , 2008, Vox sanguinis.

[16]  T. Haas,et al.  Hemostatic Changes After Crystalloid or Colloid Fluid Administration During Major Orthopedic Surgery: The Role of Fibrinogen Administration , 2007, Anesthesia and analgesia.

[17]  Dougald M Monroe,et al.  Coagulation 2006: a modern view of hemostasis. , 2007, Hematology/oncology clinics of North America.

[18]  Rainer Hofmann,et al.  Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. , 2006, European urology.

[19]  Dougald M Monroe,et al.  What does it take to make the perfect clot? , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[20]  G. Bartsch,et al.  Safer transurethral resection of the prostate: coagulating intermittent cutting reduces hemostatic complications. , 2006, The Journal of urology.

[21]  K. Taari,et al.  Tranexamic acid in control of primary hemorrhage during transurethral prostatectomy. , 2004, Urology.

[22]  M. Foster,et al.  Transurethral prostate resection and bleeding: a randomized, placebo controlled trial of role of finasteride for decreasing operative blood loss. , 2002, The Journal of urology.

[23]  W. Mebust,et al.  Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. , 2002, The Journal of urology.

[24]  R. Hahn,et al.  Blood loss during transurethral resection of the prostate after 3 months of treatment with finasteride. , 2001, Urology.

[25]  J. Hagerty,et al.  Pretreatment with finasteride decreases perioperative bleeding associated with transurethral resection of the prostate. , 2000, Urology.

[26]  J. Roberts,et al.  Immediate and postoperative complications of transurethral prostatectomy in the 1990s. , 1999, The Journal of urology.

[27]  E. Vahtera,et al.  Hemostatic Factors and Replacement of Major Blood Loss with Plasma-Poor Red Cell Concentrates , 1995, Anesthesia and analgesia.

[28]  R. Hahn,et al.  Blood loss during transurethral resection of the prostate as measured by the HemoCue photometer. , 1993, Scandinavian journal of urology and nephrology.

[29]  A T Cockett,et al.  Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. , 1989, The Journal of urology.

[30]  R. Sharifi,et al.  Safety and efficacy of intravesical aminocaproic acid for bleeding after transurethral resection of prostate. , 1986, Urology.